PDB14 USING HEALTH OUTCOMES MODELING TO ASSESS THE BENEFIT-RISK PROFILE OF EXENATIDE ONCE-WEEKLY VERSUS INSULIN GLARGINE FOR PATIENTS WITH TYPE-2 DIABETES
May 1, 2011, 00:00
10.1016/j.jval.2011.02.522
https://www.valueinhealthjournal.com/article/S1098-3015(11)00661-9/fulltext
Title :
PDB14 USING HEALTH OUTCOMES MODELING TO ASSESS THE BENEFIT-RISK PROFILE OF EXENATIDE ONCE-WEEKLY VERSUS INSULIN GLARGINE FOR PATIENTS WITH TYPE-2 DIABETES
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)00661-9&doi=10.1016/j.jval.2011.02.522
First page :
A93
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1085